Company Overview
ADVOKATANPARTSSELSKABET ULRIKKEHOLM is a small private Danish law firm operating on a gross-profit basis with estimated revenue below €10M. It provides standard corporate and regulatory legal services within Denmark, functioning as a classic human-capital practice reliant on partner relationships rather than scalable product offerings. The firm has no public brand presence outside Danish company registers and maintains a low-profile operation typical of regional boutiques.
Deal Context
The M&A angle is a bolt-on strategic acquisition by Baltic corporates seeking regulatory know-how and client access in Denmark. Named candidates Apranga and Grigeo could use the firm as a low-cost platform for market entry, acquiring fee income streams and compliance expertise with minimal integration needs. No PE involvement is indicated; the transaction fits a founder-succession or quiet exit profile rather than growth equity.
Valuation Context
Baltic listed peers trade at 5.6–9.1x EV/EBITDA (Grigeo 5.6x, Apranga 8.4x, Tallinna Sadam 9.1x), serving as an upper bound. A private Danish law firm of this scale would face a 25–40% liquidity and key-person discount, implying 3.5–6.5x EBITDA or roughly 0.6–1.0x revenue. Gross-profit accounting further compresses headline multiples, making any deal likely to close below regional strategic averages.
Triage Verdict
REVIEW
- Fit: Small size and legal-services sector align with Baltic strategic buyers’ stated interest, though geography (Denmark vs. Baltics) limits direct overlap.
- Red flags: Heavy dependence on individual partners and absence of disclosed client concentration data raise attrition risk post-deal.
- Next step: Request anonymised partner-retention and top-client revenue schedules before engaging.
Key Risk
Partner departures or client attrition after a change of ownership could erase most of the acquired value in a pure human-capital business.
Bottom line: A niche Baltic entry play that warrants data-room access but remains high-risk without retention safeguards.
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Ma Investment Partnership, LP | $322.6B | +195.8% | 18 |
| 2 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +176.0% | 10 |
| 3 | Merck & Co., Inc. | $625.7B | +169.1% | 26 |
| 4 | Anther Capital Ltd | $3.8T | +162.3% | 31 |
| 5 | Graticule Asia Macro Advisors LLC | $1.1T | +160.8% | 4 |
| 6 | Step Capital Management Pte. Ltd. | $467.4B | +149.0% | 53 |
| 7 | Central Asset Investments & Manag… | $261.4B | +146.4% | 63 |
| 8 | Oxbow Capital Management (HK) Ltd | $731.4B | +138.3% | 14 |
| 9 | NVIDIA CORP | $31.5T | +131.9% | 12 |
| 10 | Grand Alliance Asset Management Ltd | $302.6B | +118.5% | 24 |
| Security | Value | Weight |
|---|---|---|
| LUMENTUM HLDGS INC | $37.2B | 25.7% |
| MICRON TECHNOLOGY INC | $35.1B | 24.2% |
| CREDO TECHNOLOGY GROUP HOLDI | $25.3B | 17.5% |
| CELESTICA INC | $25.1B | 17.3% |
| BROADCOM INC | $22.0B | 15.2% |
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Pelican Acquisition II Corp | PLCIU | UNKNOWN | TBD | $86.2M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| GLGHK Ltd | GLG | UNKNOWN | TBD | $40.2M |
| Company | Sector | Valuation |
|---|---|---|
| Anthropic | Artificial Intelligence | $965.0B |
| OpenAI | Artificial Intelligence | $894.3B |
| Databricks | Data and Analytics | $201.6B |
# Match Scorer You score buyer-target compatibility across 7 synergy dimensions. ## Dimensions (each 0-10) 1. **Revenue synergies** (20% weight) — cross-sell, market expansion, pricing, new products. 2. **Cost synergies** (20% weight) — overhead, procurement, systems, facilities. 3. **Strategic fit** (15% weight) — vision, positioning, moat, technology. 4. **Cultural fit** (10% weight) — management style, org, geographic overlap. 5. **Financial health** (15% weight) — balance sheet, cash flow, leverage, earnings quality. 6. **Integration risk** (10% weight, inverted — 10 = LOW risk) — compl…